Novocure [NVCR] vs Artivion [AORT] Detailed Stock Comparison

Novocure Ltd.

NASDAQ
Loading...

Artivion Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Novocure Ltd. wins in 6 metrics, Artivion Inc. wins in 13 metrics, with 0 ties. Artivion Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Novocure Ltd. Artivion Inc. Better
P/E Ratio (TTM) -10.32 179.71 Artivion Inc.
Price-to-Book Ratio 4.04 4.03 Artivion Inc.
Debt-to-Equity Ratio 72.95 57.67 Artivion Inc.
PEG Ratio 0.16 -1.59 Novocure Ltd.
EV/EBITDA -8.82 36.67 Artivion Inc.
Profit Margin (TTM) -20.79% 2.21% Artivion Inc.
Operating Margin (TTM) -21.33% 8.09% Artivion Inc.
EBITDA Margin (TTM) N/A 8.09% N/A
Return on Equity -38.89% 2.70% Artivion Inc.
Return on Assets (TTM) -9.06% 2.34% Artivion Inc.
Free Cash Flow (TTM) $-75.68M $839,000 Artivion Inc.
1-Year Return 1.31% -28.85% Novocure Ltd.
Price-to-Sales Ratio (TTM) 2.16 4.15 Novocure Ltd.
Enterprise Value $1.19B $1.97B Artivion Inc.
EV/Revenue Ratio 1.82 4.47 Novocure Ltd.
Gross Profit Margin (TTM) 75.82% 63.06% Novocure Ltd.
Revenue per Share (TTM) $6 $10 Artivion Inc.
Earnings per Share (Diluted) $-1.22 $0.21 Artivion Inc.
Beta (Stock Volatility) 0.82 1.62 Novocure Ltd.
Short % of Float 12.45% 4.13% Artivion Inc.

Novocure Ltd. vs Artivion Inc. Stock Performance Analysis

Loading Price Chart...

NVCR
AORT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Novocure Ltd.-1.01%4.45%0.11%42.16%35.70%34.15%
Artivion Inc.4.83%3.33%-7.47%-43.66%-53.56%-52.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Novocure Ltd.1.31%-59.78%-91.85%63.27%-2.74%-2.74%
Artivion Inc.-28.85%25.55%-29.37%70.34%288.03%318.75%

Performance & Financial Health Analysis: Novocure Ltd. vs Artivion Inc.

MetricNVCRAORT
Market Information
Market Cap i$1.46B$1.83B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,138,762273,552
90 Day Avg. Volume i1,141,014406,554
Last Close$17.60$21.07
52 Week Range$9.82 - $18.92$19.16 - $48.25
% from 52W High-6.98%-56.33%
All-Time High$232.76 (Jun 21, 2021)$48.25 (Dec 17, 2025)
% from All-Time High-92.44%-56.33%
Growth Metrics
Quarterly Revenue Growth0.08%0.19%
Quarterly Earnings Growth0.08%0.19%
Financial Health
Profit Margin (TTM) i-0.21%0.02%
Operating Margin (TTM) i-0.21%0.08%
Return on Equity (TTM) i-0.39%0.03%
Debt to Equity (MRQ) i72.9557.67
Cash & Liquidity
Book Value per Share (MRQ)$3.03$9.37
Cash per Share (MRQ)$3.93$1.36
Operating Cash Flow (TTM) i$-49,031,000$39.88M
Levered Free Cash Flow (TTM) i$-37,975,376$-20,097,624
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Novocure Ltd. vs Artivion Inc.

MetricNVCR (Apr 24, 2026)AORT (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-10.32179.71
Forward P/E i-10.4932.65
PEG Ratio i0.16-1.59
Price to Sales (TTM) i2.164.15
Price to Book (MRQ) i4.044.03
Market Capitalization
Market Capitalization i$1.46B$1.83B
Enterprise Value i$1.19B$1.97B
Enterprise Value Metrics
Enterprise to Revenue i1.824.47
Enterprise to EBITDA i-8.8236.67
Risk & Other Metrics
Beta i0.821.62
Book Value per Share (MRQ) i$3.03$9.37

Financial Statements Comparison: Novocure Ltd. vs Artivion Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNVCR (2025)AORT (2025)
Revenue/Sales i655.35M441.33M
Cost of Goods Sold i166.88M157.10M
COGS % of Revenue i25.5%35.6%
Gross Profit i488.47M284.23M
Gross Margin i74.5%64.4%
Research & Development i224.54M30.99M
Operating Income (EBIT) i-153.80M26.75M
Operating Margin i-23.5%6.1%
EBITDA i-100.24M59.48M
EBITDA Margin i-15.3%13.5%
Pre-Tax Income i-136.25M14.78M
Pre-Tax Income % of Revenue i-20.8%3.3%
Income Tax i-23,0005.01M
Income Tax % of Revenue i0.0%1.1%
Net Income (Profit) i-136.23M9.77M
Profit Margin i-20.8%2.2%

Balance Sheet & Liquidity Metrics

MetricNVCR (2025)AORT (2025)
Cash & Equivalents i93.55M64.91M
Total Current Assets i646.73M358.08M
Total Current Assets % of Revenue i98.7%81.1%
Total Current Liabilities i223.23M101.56M
Total Current Liabilities % of Revenue i34.1%23.0%
Long-Term Debt i236.69M252.24M
Long-Term Debt % of Revenue i36.1%57.2%
Total Shareholders Equity i340.47M448.23M
Retained Earnings i-1.29B-51.50M
Retained Earnings % of Revenue i-196.9%-11.7%
Property, Plant & Equipment i115.82M34.70M

Cash Flow Statement Comparison

MetricNVCR (2025)AORT (2025)
Operating Cash Flow i-50.83M41.11M
Operating Cash Flow % of Revenue i-7.8%9.3%
Capital Expenditures i-26.65MN/A
Free Cash Flow i-75.68M839,000
FCF Margin i-11.5%0.2%
Debt Repayment i-560.95M-2.46M
Common Stock Repurchase iN/A0

Short Interest & Institutional Ownership Analysis

MetricNVCRAORT
Shares Short i9.06M1.67M
Short Ratio i6.784.28
Short % of Float i12.45%4.13%
Shares Outstanding i112.49M47.84M
Float Shares i94.63M45.40M
% Held by Insiders i9.32%4.52%
% Held by Institutions i85.24%91.48%
% Held by Public i5.44%4.00%

Dividend Analysis & Yield Comparison: Novocure Ltd. vs Artivion Inc.

MetricNVCRAORT
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A